Epidermal growth factor receptor exon 19 deletions predict complete regression of multiple intracranial metastases in two cases of non-small cell lung cancer treated with erlotinib.

Source:http://linkedlifedata.com/resource/pubmed/id/19550250

Download in:

View as

General Info

PMID
19550250